Norges Bank’s Enfusion, Inc. ENFN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-445,652
Closed -$5.5M 2189
2022
Q3
$5.5M Hold
445,652
﹤0.01% 1733
2022
Q2
$4.55M Hold
445,652
﹤0.01% 1791
2022
Q1
$5.67M Sell
445,652
-50,000
-10% -$764K ﹤0.01% 1845
2021
Q4
$10.4M Buy
+495,652
New +$10M ﹤0.01% 1749

Other funds holding ENFN

Norges Bank's ENFN Position: Q4 2022 in Review

Norges Bank sold out of Enfusion, Inc. (ENFN) in Q4 2022, closing a stake of 445,652 shares — an estimated $5.5M sold.

Norges Bank first reported a position in ENFN in Q4 2021 and held it in 4 quarters. The position peaked at $10.4M in Q4 2021. 74 funds tracked by Wall St. Rank hold ENFN as of Q4 2022.

  • Norges Bank reported no remaining Enfusion, Inc. position as of Q4 2022 after selling out during the quarter.
  • Norges Bank sold 445,652 Enfusion, Inc. shares in Q4 2022, an estimated $5.5M.
  • Norges Bank first reported a position in Enfusion, Inc. in Q4 2021 and held it in 4 quarters.
  • Norges Bank's Enfusion, Inc. position peaked at $10.4M in Q4 2021.
  • 74 funds tracked by Wall St. Rank held Enfusion, Inc. as of Q4 2022.

Based on Norges Bank's 13F filing for Q4 2022, filed 14 Feb 2023.